Sigyn Therapeutics, Inc. (OTCMKTS:SIGY – Get Free Report)’s share price rose 28.8% during trading on Friday . The company traded as high as $4.12 and last traded at $4.12. Approximately 500 shares changed hands during mid-day trading, an increase of 67% from the average daily volume of 300 shares. The stock had previously closed at $3.20.
Sigyn Therapeutics Stock Up 28.8 %
The company has a 50-day simple moving average of $3.42 and a 200 day simple moving average of $4.79.
Sigyn Therapeutics Company Profile
Sigyn Therapeutics, Inc, a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats.
Featured Articles
- Five stocks we like better than Sigyn Therapeutics
- What is a Death Cross in Stocks?
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- What is a Low P/E Ratio and What Does it Tell Investors?
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- 3 Warren Buffett Stocks to Buy Now
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for Sigyn Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sigyn Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
